A new year, a new name and a vision for growth We are pleased to announce that Protein Design Labs, Inc., and ESP Pharma, Inc., will now be known as PDL BioPharma, Inc. Our new name reflects our heritage as a leader in antibody technology as well as our new commercial focus and expertise in the acute-care hospital market. With our portfolio of marketed products, late-stage pipeline and record of technological and financial strength, we're positioned for success as a premier biopharmaceutical company focused on developing and commercializing innovative therapies for severe or life-threatening illnesses. 2006 is expected to be an exciting time for the employees, customers, investors and partners of PDL BioPharma. Join us as we celebrate our past, present and future. Please visit the new PDL BioPharma website for information about our company, products, pipeline and much more. http://www.pdl.com